See full prescribing information for dosing and administration information. (2) Dosage Forms and Strengths 100 mg/mL concentration (3): • Single-dose prefilled syringes: 30 mg/0.3 mL, 40 mg/0.4 mL • Single-dose graduated prefilled syringes: 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg...
Reveals that Aventis SA has issued a Dear Healthcare Professional letter advising of changes to Lovenox prescribing information and which was posted on the Web site of the U.S. Food & Drug Administration on August 17, 2004. Dosage adjustment in patients with severe, mild or moderate renal ...
Lovenox® is indicated to help reduce the risk of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE). Read full important safety information.
Lovenox - Detailed Prescribing InformationDrugs